Read More Pharma Industry News Novavax shares rally after FDA approves non-mRNA COVID-19 vaccine for at-risk groups Novavax stock surged 25% after FDA approved its non-mRNA COVID-19 vaccine Nuvaxovid. Find out what triggered this rally and what it means for investors. byPallavi MadhirajuMay 19, 2025